RSV Vaccine (GSK)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV Vaccine (GSK), covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease [Phase 3]